Starting on August 26, 2023, in honor of Women’s Equality Day in the United States, which commemorates the 1920 law granting women the right to vote, OncoDaily launched an initiative to spotlight 100 remarkable female leaders in oncology worldwide. Each week, 10 inspiring women were introduced, culminating in the full list and an updated edition in 2024.
Continuing this tradition, we are proud to present the 2025 list of 100 Influential Women in Oncology to Follow on Social Media.
While there are countless exceptional women leaders in oncology who deserve recognition, we acknowledge that we couldn’t feature everyone. This initiative is ongoing, and we look forward to your nominations for 2026. We’ll be sharing the submission link soon.
Here are the fourth 10 of 100 Influential Women in Oncology to follow in 2025:
Her Royal Highness Princess Dina Mired of Jordan is a humanitarian, passionate global advocate for Cancer Control and Non-Communicable Diseases (NCDs) and mother of a cancer survivor. She is the Patron of the International Society of Pediatric Oncology (SIOP), Honorary President of the EORTC Research Fund, and Honorary Ambassador of Harvard Global Health Win-Win Initiative.
Her Royal Highness is the Past-President of the Union for International Cancer Control (UICC), and former Director-General of the King Hussein Cancer Foundation. She has played a key role in OncoDaily’s First Global Summit on War and Cancer, OncoThon, Global Cancer Movement and her advocacy continues to influence global health policies, making her one of the most respected figures in cancer control.
Follow HRH Princess Dina Mired on X and LinkedIn.
Rachna T. Shroff is the Associate Director of Clinical Investigations and Co-Leader of the Gastrointestinal Clinical Research Team at the University of Arizona Cancer Center (UACC). She is also Professor with tenure in the Department of Medicine, Chief of the Division of Hematology and Oncology, Medical Director for the Oncology Service Line, and Associate Dean for Clinical and Translational Research at the University of Arizona College of Medicine – Tucson.
Dr. Shroff is an internationally recognized investigator in pancreatic and hepatobiliary cancers. She serves as Hepatobiliary Subcommittee Co-Chair for SWOG, was Chair of the ASCO GI Cancers Symposium 2024, and is a member of the ASCO Nominating Committee and the Cholangiocarcinoma Foundation’s Scientific and Medical Advisory Board.
Follow Dr. Rachna Shroff on X and LinkedIn.
Narjust Florez is Associate Medical Director of the Cancer Care Access Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She specializes in targeted therapy for lung cancer and women’s cancer survivorship and leads the largest study on sexual health in women with lung cancer.
She is also the founder of the Florez Lab, advancing lung cancer research and mentoring underrepresented trainees in medicine. Dr. Florez is a prominent voice on cancer health disparities and gender equity reflected by her work in creating inclusivity in oncology.
Follow Dr. Narjust Florez on X and LinkedIn.
Lacy Hubbard is the Founding President and CEO of the Elekta Foundation, a nonprofit dedicated to improving access to cancer care in low-income countries, particularly through radiotherapy capacity-building.
With many years of global experience in the radiation oncology industry, she leads transformational programs—such as the “One Egg A Day” initiative in Rwanda, which provides nutritional support to women undergoing breast and cervical cancer screening.
Follow Lacy Hubbard on LinkedIn.
Idalid “Ivy” Franco is a Radiation Oncologist at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, and an Instructor at Harvard Medical School. She is the inaugural Director of Equity, Access, and Inclusion for the Department of Radiation Oncology, with a clinical focus on gynecologic cancers and expertise in brachytherapy.
Her research examines cancer outcomes in vulnerable populations and the impact of social determinants of health. A national leader in diversity and equity, Dr. Franco has developed initiatives to reduce disparities and expand access to cancer care.
Follow Dr. Idalid Franco on X and LinkedIn.
Misty Dawn Shields is an Assistant Professor at Indiana University School of Medicine and Associate Member of Experimental and Developmental Therapeutics at the IU Simon Comprehensive Cancer Center. A thoracic medical oncologist, she leads The Shields Lab, advancing translational research and clinical trials in small cell lung cancer (SCLC).
She is the founder of Small Cell SMASHERS, an advocacy initiative with the LUNGevity Foundation, and has been recognized with the 2025 Conquer Cancer Career Development Award and the Women Who Conquer Cancer Mentorship Award.
Follow Dr. Misty Dawn Shields on X and LinkedIn.
Joyce Balagadde Kambugu is the Head of Pediatric Oncology at the Uganda Cancer Institute (UCI), where she established the country’s first dedicated pediatric oncology unit and fellowship program. With more than a decade of experience, she leads efforts to expand childhood cancer services to regional hospitals and strengthen Uganda’s National Cancer Control Plan.
She serves as Continental President for Africa on the SIOP Board of Directors and contributes to global networks on essential medicines, outcomes, and pediatric cancer care in low-resource settings. Dr. Kambugu is a passionate advocate for improving childhood cancer survival and equity across Africa.
Follow Dr. Joyce Kambugu on X and LinkedIn.
Shweta Bansal is the Head of Pediatric Hemato-Oncology at Sir H. N. Reliance Foundation Hospital in Mumbai. Trained at Tata Memorial Hospital, St. Jude Children’s Research Hospital, and NUH Singapore, she established bone marrow transplant programs at Reliance Hospital and LTMGH.
She has served as Treasurer of the Pediatric Hemato-Oncology Society of India and is a member of the Ethics Committee of the Indian Council of Medical Research. Her work continues to shape pediatric cancer and transplant care in India.
Follow Dr. Shweta Bansal on X and LinkedIn.
Isabelle Villadary is the Head of the Childhood Cancer Program at Foundation S – The Sanofi Collective, where she leads efforts to ensure every child diagnosed with cancer has an equal chance of survival, regardless of where they live.
Under her leadership, Foundation S works with health systems, NGOs, and regional and international stakeholders to adapt resources and drive impact – focusing on early diagnosis, survivor support, and holistic childhood cancer care. She also plays a critical role in programs like “My Child Matters” and networks such as Faros De Vida, which aim to enhance survivor outcomes and assess health needs across Latin America.
Follow Isabelle Villadary on LinkedIn.
Triparna Sen is a Professor of Internal Medicine at The Ohio State University and Director of the Lung Cancer Preclinical Therapeutics Platform at the OSUCCC – James. Dr. Sen also serves on the Board of Directors of the International Association for the Study of Lung Cancer (IASLC).
A dedicated mentor and advocate, she is committed to shaping the next generation of scientists while amplifying patient voices in oncology research, reflected by the honors she has received including the AAAS Wachtel Cancer Research Award and the “40 Under 40 in Cancer” Emerging Leaders Award.
Follow Dr. Triparna Sen on X and LinkedIn.
See also:
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025 – Part 2
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025 – Part 1
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024